Search Results - "Stanbury, Trevor"

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study by Edeline, Julien, Benabdelghani, Meher, Bertaut, Aurélie, Watelet, Jérôme, Hammel, Pascal, Joly, Jean-Paul, Boudjema, Karim, Fartoux, Laetitia, Bouhier-Leporrier, Karine, Jouve, Jean-Louis, Faroux, Roger, Guerin-Meyer, Véronique, Kurtz, Jean-Emmanuel, Assénat, Eric, Seitz, Jean-François, Baumgaertner, Isabelle, Tougeron, David, de la Fouchardière, Christelle, Lombard-Bohas, Catherine, Boucher, Eveline, Stanbury, Trevor, Louvet, Christophe, Malka, David, Phelip, Jean-Marc

“…No standard adjuvant treatment currently is recommended in localized biliary tract cancer (BTC) after surgical resection. We aimed to assess whether…”
Get full text

Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance by Pernot, Simon, Terme, Magali, Radosevic-Robin, Nina, Castan, Florence, Badoual, Cécile, Marcheteau, Elie, Penault-Llorca, Fréderique, Bouche, Olivier, Bennouna, Jaafar, Francois, Eric, Ghiringhelli, Francois, De La Fouchardiere, Christelle, Samalin, Emmanuelle, Baptiste Bachet, Jean, Borg, Christophe, Boige, Valérie, Voron, Thibault, Stanbury, Trevor, Tartour, Eric, Gourgou, Sophie, Malka, David, Taieb, Julien

“…Background The correlation between immune cells and the Lauren classification subtypes and their prognostic impact in advanced gastric cancer (AGC) are…”
Get full text

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial by Bidard, François-Clément, Kiavue, Nicolas, Ychou, Marc, Cabel, Luc, Stern, Marc-Henri, Madic, Jordan, Saliou, Adrien, Rampanou, Aurore, Decraene, Charles, Bouché, Olivier, Rivoire, Michel, Ghiringhelli, François, Francois, Eric, Guimbaud, Rosine, Mineur, Laurent, Khemissa-Akouz, Faiza, Mazard, Thibault, Moussata, Driffa, Proudhon, Charlotte, Pierga, Jean-Yves, Stanbury, Trevor, Thézenas, Simon, Mariani, Pascale

“…The management of patients with colorectal cancer (CRC) and potentially resectable liver metastases (LM) requires quick assessment of mutational status and of…”
Get full text

Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup by Kerckhove, Nicolas, Busserolles, Jérome, Stanbury, Trevor, Pereira, Bruno, Plence, Valérie, Bonnetain, Franck, Krakowski, Ivan, Eschalier, Alain, Pezet, Denis, Balayssac, David

“…IntroductionMost patients (>70%) experience acute neuropathic symptoms shortly after oxaliplatin infusions. These symptoms are not always resolved between…”
Get full text

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7 by Quenet, François, Elias, Dominique, Roca, Lise, Goere, Diane, Ghouti, Laurent, Pocard, Marc, Facy, Olivier, Arvieux, Catherine, Lorimier, Gerard, Pezet, Denis, Marchal, Frederic, Loi, Valeria, Meeus, Pierre, De Forges, Hélène, Stanbury, Trevor, Paineau, Jacques, Glehen, Olivier

“…Abstract only LBA3503 Background: Promising results have been obtained during the last decade using cytoreductive surgery (CRS) plus HIPEC for selected…”
Get full text

Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial by Edeline, Julien, Bonnetain, Franck, Phelip, Jean Marc, Watelet, Jérôme, Hammel, Pascal, Joly, Jean-Paul, Ben Abdelghani, Meher, Rosmorduc, Olivier, Bouhier-Leporrier, Karine, Jouve, Jean-Louis, Faroux, Roger, Guerin Meyer, Véronique, Assenat, Eric, Seitz, Jean Francois, Malka, David, Louvet, Christophe, Bertaut, Aurelie, Juzyna, Beata, Stanbury, Trevor, Boucher, Eveline

“…Abstract only 225 Background: No standard post-surgery adjuvant treatment is currently recommended in localized biliary tract cancer (BTC). Gemcitabine…”
Get full text

Reformatsky reactions with N-arylpyrrolidine-2-thiones: synthesis of tricyclic analogues of quinolone antibacterial agents by Michael, Joseph P, de Koning, Charles B, Hosken, Gladys D, Stanbury, Trevor V

“…A convenient synthesis of 5-oxo-1,2,3,5-tetrahydropyrrolo[1,2- a]quinoline-4-carboxylic acids, tricyclic analogues of the quinolone antibiotics, is described…”
Get full text

Asymmetric synthesis of a tetracyclic model for the aziridinomitosenes by Michael, Joseph P, de Koning, Charles B, Petersen, Riaan L, Stanbury, Trevor V

“…The conversion of (−)-2,3- O-isopropylidene- d-erythronolactone ( 9 ) into the N-phosphorylated aziridine 20 , a model for the fundamental structure of…”
Get full text

Chromogranin A: a useful biomarker in castration-resistant prostate cancer by Ploussard, Guillaume, Rozet, François, Roubaud, Guilhem, Stanbury, Trevor, Sargos, Paul, Roupret, Morgan

“…Purpose The natural history of prostate cancer (PC) almost always evolves to castration-resistant prostate cancer (CRPC) status, sometimes comprising pure or…”
Get full text

A study to assess the diagnostic performance of a digital remote monitoring tool for patients with cancer: The POSITEA-VA study by Parnot, Charles Georges, Montestruc, François, Stanbury, Trevor, Pierache, Adeline, Labourey, Jean-Luc, Helissey, Carole, Champoiseau, François-Guirec

“…1605 Background: Remote monitoring of cancer patients is known to improve survival by allowing early reporting and management of adverse events (AEs)…”
Get full text

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects by Pernot, Simon, Badoual, Cecile, Terme, Magali, Castan, Florence, Cazes, Aurelie, Bouche, Olivier, Bennouna, Jaafar, Francois, Eric, Ghiringhelli, Francois, De La Fouchardiere, Christelle, Samalin, Emmanuelle, Bachet, Jean Baptiste, Borg, Christophe, Ducreux, Michel, Marcheteau, Elie, Stanbury, Trevor, Gourgou, Sophie, Malka, David, Taieb, Julien

“…Abstract Background The identification of dynamic biomarkers in advanced gastric and oesogastric junction adenocarcinoma (GOA) could help to tailor strategies…”
Get full text

Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial by Bennouna, Jaafar, Hiret, Sandrine, Bertaut, Aurelie, Bouché, Olivier, Deplanque, Gael, Borel, Christian, François, Eric, Conroy, Thierry, Ghiringhelli, François, des Guetz, Gaëtan, Seitz, Jean-François, Artru, Pascal, Hebbar, Mohamed, Stanbury, Trevor, Denis, Marc G, Adenis, Antoine, Borg, Christophe

“…Second-line treatment with chemotherapy plus bevacizumab or cetuximab is a valid option for metastatic colorectal cancer. To evaluate the progression-free…”
Get more information

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial by Malka, David, François, Eric, Penault-Llorca, Frédérique, Castan, Florence, Bouché, Olivier, Bennouna, Jaafar, Ghiringhelli, François, de la Fouchardière, Christelle, Borg, Christophe, Samalin, Emmanuelle, Bachet, Jean-Baptiste, Raoul, Jean-Luc, Miglianico, Laurent, Bengrine-Lefèvre, Leila, Dahan, Laetitia, Lecaille, Cédric, Aparicio, Thomas, Stanbury, Trevor, Perrier, Hervé, Cayre, Anne, Laurent-Puig, Pierre, Gourgou, Sophie, Emile, Jean-François, Taïeb, Julien

“…Epidermal growth factor receptor (EGFR) and hepatocyte growth factor (HGF)/mesenchymal–epithelial transition (MET) pathways, which promote tumour growth and…”
Get full text

Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03) by Faivre, Jean-Christophe, Peiffert, Didier, Vendrely, Véronique, Lemanski, Claire, Hannoun-Levi, Jean-Michel, Mirabel, Xavier, Stanbury, Trevor, Salleron, Julia, Guillemin, Francis

“…To carry out a prognosis study of the prospective studies KANAL 2 and ACCORD 03 in order to highlight new prognostic factors of colostomy-free survival in…”
Get full text

A versatile synthesis of tricyclic analogues of quinolone antibacterial agents: Use of a novel reformatsky reaction by Michael, Joseph P, de Koning, Charles B, Stanbury, Trevor V

“…A simple synthesis of tricyclic analogues of the quinolone antibiotics bearing a diverse range of substituents on the aromatic ring is described. The key steps…”
Get full text

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma by Péron, Julien, Roy, Pascal, Conroy, Thierry, Desseigne, Françoise, Ychou, Marc, Gourgou-Bourgade, Sophie, Stanbury, Trevor, Roche, Laurent, Ozenne, Brice, Buyse, Marc

“…We sought to assess the benefit-risk balance of FOLFIRINOX versus gemcitabine in patients with metastatic pancreatic adenocarcinoma. We used generalized…”
Get full text

FOLFIRINOX plus cetuximab (CET) or bevacizumab (BEV) in patients (pts) with initially unresectable colorectal liver metastases (CRLM) with BRAF mutated (mut) tumors: A subgroup analysis of the UNICANCER PRODIGE 14-ACCORD 21 (METHEP2) trial by Lopez-Crapez, Evelyne, Adenis, Antoine, Thezenas, Simon, Assenat, Eric, Francois, Eric, Guimbaud, Rosine, Chauvenet, Marion, Khemissa, Faiza, Audemar, Franck, Suc, Etienne, Rivoire, Michel, Ghiringhelli, François, Mercier-Blas, Anne, Mineur, Laurent, Becouarn, Yves, Houyau, Philippe, Stanbury, Trevor, Jouffroy-Zeller, Claire, Bouche, Olivier, Ychou, Marc

“…Abstract only…”
Get full text

A multi-centric randomized phase II trial evaluating dual targeting of the EGFR with cetuximab and afatinib versus cetuximab alone in patients with chemotherapy refractory wtKRAS metastatic colorectal cancer (UCGI 25: A UNICANCER trial) by Senellart, Helene, Samalin, Emmanuelle, Castan, Florence, Borg, Christophe, Adenis, Antoine, De La Fouchardiere, Christelle, Malka, David, Guerin-Meyer, Veronique, Francois, Eric, Ben Abdelghani, Meher, Boucher, Eveline, Andre, Thierry, Ghiringhelli, Francois, Lievre, Astrid, Stanbury, Trevor, Bennouna, Jaafar

“…Abstract only…”
Get full text

Bevacizumab or cetuximab plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wtKRAS metastatic colorectal cancer: A randomized phase II study (Prodige 18 –UNICANCER GI) by Hiret, Sandrine, Borg, Christophe, Bertaut, Aurelie, Bouche, Olivier, Adenis, Antoine, Deplanque, Gael, Francois, Eric, Conroy, Thierry, Ghiringhelli, Francois, Des Guetz, Gaetan, Seitz, Jean-François, Artru, Pascal, Stanbury, Trevor, Denis, Marc G., Bennouna, Jaafar

“…Abstract only…”
Get full text

FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial by Ychou, Marc, Rivoire, Michel, Thezenas, Simon, Guimbaud, Rosine, Ghiringhelli, Francois, Mercier-Blas, Anne, Mineur, Laurent, Francois, Eric, Khemissa, Faiza, Moussata, Driffa, Becouarn, Yves, Houyau, Philippe, Aparicio, Thomas, Adam, Rene, Galais, Marie-Pierre, Audemar, Franck, Assenat, Eric, Stanbury, Trevor, Bouche, Olivier

“…Abstract only…”
Get full text